Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jun;33(6):960–962. doi: 10.1128/aac.33.6.960

In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole.

J I Ravdin 1, J Skilogiannis 1
PMCID: PMC284263  PMID: 2548442

Abstract

Current therapy of Entamoeba histolytica infection requires use of multiple agents effective at different body sites, including the intestinal lumen, intestinal tissue, and liver. Azithromycin and CP-63,956, new extended-half-life macrolides which reach high levels in tissue, exhibit in vitro antiamebic activity at 18 or 48 h of incubation at concentrations comparable to that of erythromycin and slightly higher than that of metronidazole. Azithromycin and CP-63,956 have the potential to be useful therapeutic agents for all types of E. histolytica infection.

Full text

PDF
960

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams E. B., MacLeod I. N. Invasive amebiasis. I. Amebic dysentery and its complications. Medicine (Baltimore) 1977 Jul;56(4):315–323. doi: 10.1097/00005792-197707000-00003. [DOI] [PubMed] [Google Scholar]
  2. Cedeño J. R., Krogstad D. J. Susceptibility testing of Entamoeba histolytica. J Infect Dis. 1983 Dec;148(6):1090–1095. doi: 10.1093/infdis/148.6.1090. [DOI] [PubMed] [Google Scholar]
  3. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  4. Eubank W. B., Reeves R. E. Growth inhibition of axenic Entamoeba histolytica by tubercidin and ara-A. Am J Trop Med Hyg. 1981 Jul;30(4):900–902. doi: 10.4269/ajtmh.1981.30.900. [DOI] [PubMed] [Google Scholar]
  5. Girard A. E., Girard D., English A. R., Gootz T. D., Cimochowski C. R., Faiella J. A., Haskell S. L., Retsema J. A. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother. 1987 Dec;31(12):1948–1954. doi: 10.1128/aac.31.12.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kanani S. R., Knight R. Experiences with the use of metronidazole in the treatment of non dysenteric intestinal amoebiasis. Trans R Soc Trop Med Hyg. 1972;66(2):244–249. doi: 10.1016/0035-9203(72)90154-x. [DOI] [PubMed] [Google Scholar]
  7. Lasserre R., Jaroonvesama N., Kurathong S., Soh C. T. Single-day drug treatment of amebic liver abscess. Am J Trop Med Hyg. 1983 Jul;32(4):723–726. doi: 10.4269/ajtmh.1983.32.723. [DOI] [PubMed] [Google Scholar]
  8. Markell E. K., Havens R. F., Kuritsubo R. A., Wingerd J. Intestinal protozoa in homosexual men of the San Francisco Bay area: prevalence and correlates of infection. Am J Trop Med Hyg. 1984 Mar;33(2):239–245. doi: 10.4269/ajtmh.1984.33.239. [DOI] [PubMed] [Google Scholar]
  9. Pehrson P. O., Bengtsson E. A long-term follow up study of amoebiasis treated with metronidazole. Scand J Infect Dis. 1984;16(2):195–198. doi: 10.3109/00365548409087141. [DOI] [PubMed] [Google Scholar]
  10. Retsema J., Girard A., Schelkly W., Manousos M., Anderson M., Bright G., Borovoy R., Brennan L., Mason R. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987 Dec;31(12):1939–1947. doi: 10.1128/aac.31.12.1939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Simjee A. E., Gathiram V., Jackson T. F., Khan B. F. A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. S Afr Med J. 1985 Dec 21;68(13):923–924. [PubMed] [Google Scholar]
  12. Smith P. D., Lane H. C., Gill V. J., Manischewitz J. F., Quinnan G. V., Fauci A. S., Masur H. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med. 1988 Mar;108(3):328–333. doi: 10.7326/0003-4819-108-3-328. [DOI] [PubMed] [Google Scholar]
  13. Spillmann R., Ayala S. C., Sanchez C. E. Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers. Am J Trop Med Hyg. 1976 Jul;25(4):549–551. doi: 10.4269/ajtmh.1976.25.549. [DOI] [PubMed] [Google Scholar]
  14. Thacker S. B., Simpson S., Gordon T. J., Wolfe M., Kimball A. M. Parasitic disease control in a residential facility for the mentally retarded. Am J Public Health. 1979 Dec;69(12):1279–1281. doi: 10.2105/ajph.69.12.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES